NO306283B1 - Farmasöytisk blanding for nasal administrering omfattende polare morfinmetabolitter - Google Patents

Farmasöytisk blanding for nasal administrering omfattende polare morfinmetabolitter

Info

Publication number
NO306283B1
NO306283B1 NO942787A NO942787A NO306283B1 NO 306283 B1 NO306283 B1 NO 306283B1 NO 942787 A NO942787 A NO 942787A NO 942787 A NO942787 A NO 942787A NO 306283 B1 NO306283 B1 NO 306283B1
Authority
NO
Norway
Prior art keywords
pct
polar
agents
morphine
nasal administration
Prior art date
Application number
NO942787A
Other languages
English (en)
Norwegian (no)
Other versions
NO942787D0 (no
NO942787L (no
Inventor
Lisbeth Illum
Original Assignee
Danbiosyst Uk Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Danbiosyst Uk Ltd filed Critical Danbiosyst Uk Ltd
Publication of NO942787D0 publication Critical patent/NO942787D0/no
Publication of NO942787L publication Critical patent/NO942787L/no
Publication of NO306283B1 publication Critical patent/NO306283B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Otolaryngology (AREA)
  • Emergency Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO942787A 1992-02-05 1994-07-27 Farmasöytisk blanding for nasal administrering omfattende polare morfinmetabolitter NO306283B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB929202464A GB9202464D0 (en) 1992-02-05 1992-02-05 Composition for nasal administration
PCT/GB1993/000228 WO1993015737A1 (fr) 1992-02-05 1993-02-04 Compositions pour l'administration par voie nasale contenant des metabolites polaires d'analgesiques opioïdes

Publications (3)

Publication Number Publication Date
NO942787D0 NO942787D0 (no) 1994-07-27
NO942787L NO942787L (no) 1994-07-27
NO306283B1 true NO306283B1 (no) 1999-10-18

Family

ID=10709891

Family Applications (1)

Application Number Title Priority Date Filing Date
NO942787A NO306283B1 (no) 1992-02-05 1994-07-27 Farmasöytisk blanding for nasal administrering omfattende polare morfinmetabolitter

Country Status (12)

Country Link
US (1) US5629011A (fr)
EP (1) EP0625044B1 (fr)
JP (1) JP3958352B2 (fr)
AT (1) ATE171872T1 (fr)
AU (1) AU665806B2 (fr)
CA (1) CA2127805C (fr)
DE (1) DE69321458T2 (fr)
DK (1) DK0625044T3 (fr)
ES (1) ES2123660T3 (fr)
GB (2) GB9202464D0 (fr)
NO (1) NO306283B1 (fr)
WO (1) WO1993015737A1 (fr)

Families Citing this family (122)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1247472B (it) * 1991-05-31 1994-12-17 Fidia Spa Processo per la preparazione di microsfere contenenti componenti biologicamente attivi.
US5266331A (en) * 1991-11-27 1993-11-30 Euroceltique, S.A. Controlled release oxycodone compositions
US5478577A (en) * 1993-11-23 1995-12-26 Euroceltique, S.A. Method of treating pain by administering 24 hour oral opioid formulations exhibiting rapid rate of initial rise of plasma drug level
US20080075781A1 (en) * 1992-11-25 2008-03-27 Purdue Pharma Lp Controlled release oxycodone compositions
DE69434304T2 (de) * 1993-03-26 2005-12-29 Merkus, Franciscus Wilhelmus H.M. Pharmazeutische Zusammensetzungen zur intranasalen Verabreichung von Dihydroergotamin
US20070275062A1 (en) * 1993-06-18 2007-11-29 Benjamin Oshlack Controlled release oxycodone compositions
IL110014A (en) * 1993-07-01 1999-11-30 Euro Celtique Sa Solid controlled-release oral dosage forms of opioid analgesics
US7740881B1 (en) 1993-07-01 2010-06-22 Purdue Pharma Lp Method of treating humans with opioid formulations having extended controlled release
US5879705A (en) * 1993-07-27 1999-03-09 Euro-Celtique S.A. Sustained release compositions of morphine and a method of preparing pharmaceutical compositions
GB2282758A (en) * 1993-08-23 1995-04-19 Euro Celtique Sa Oral morphine-6-glucuronide compositions
DE4403709A1 (de) * 1994-02-07 1995-08-10 Lohmann Therapie Syst Lts Pharmazeutische Zusammensetzung zur systemischen transdermalen Verabreichung mit dem Wirkstoff Morphin-6-glucuronid
US5679714A (en) * 1995-06-07 1997-10-21 Weg; Stuart L. Administration of ketamine for detoxification and treatment of tobacco addiction
US5543434A (en) * 1994-02-25 1996-08-06 Weg; Stuart L. Nasal administration of ketamine to manage pain
WO1996002275A1 (fr) * 1994-07-20 1996-02-01 Toyama Chemical Co., Ltd. Onguent buccal a liberation prolongee
GB9416884D0 (en) * 1994-08-20 1994-10-12 Danbiosyst Uk Drug delivery compositions
GB9419979D0 (en) * 1994-10-04 1994-11-16 Medeva Holdings Bv Vaccine compositions
GB9519363D0 (en) 1995-09-22 1995-11-22 Euro Celtique Sa Pharmaceutical formulation
GB9522351D0 (en) * 1995-11-01 1996-01-03 Medeva Holdings Bv Vaccine compositions
US6017963A (en) 1995-11-14 2000-01-25 Euro-Celtique, S.A. Formulation for intranasal administration
GB9525083D0 (en) * 1995-12-07 1996-02-07 Danbiosyst Uk Vaccine compositions
GB9606188D0 (en) * 1996-03-23 1996-05-29 Danbiosyst Uk Pollysaccharide microspheres for the pulmonary delivery of drugs
US5976573A (en) * 1996-07-03 1999-11-02 Rorer Pharmaceutical Products Inc. Aqueous-based pharmaceutical composition
US6248789B1 (en) 1996-08-29 2001-06-19 Stuart L. Weg Administration of ketamine to manage pain and to reduce drug dependency
US6403602B1 (en) * 1997-02-20 2002-06-11 The University Of Kentucky Research Foundation Morphine-6-sulfate analogues and their use for the treatment of pain
GB9710699D0 (en) 1997-05-24 1997-07-16 Danbiosyst Uk Gastro-retentive controlled release system
JP2005281315A (ja) * 1997-07-02 2005-10-13 Aventis Pharmaceuticals Holdings Inc 水性薬理組成物
US6391452B1 (en) 1997-07-18 2002-05-21 Bayer Corporation Compositions for nasal drug delivery, methods of making same, and methods of removing residual solvent from pharmaceutical preparations
AU747211B2 (en) * 1997-07-18 2002-05-09 Bayer Corporation Methods of removing residual solvent from nasal drug delivery compositions
JP4234803B2 (ja) * 1997-10-27 2009-03-04 久光製薬株式会社 薬物放出速度が制御された医薬組成物
FR2771929B1 (fr) * 1997-12-09 2001-02-23 Biovector Therapeutics Utilisation dans une composition pharmaceutique pour l'administration par voie nasale de particules hydrophiles pour la delivrance d'agents actifs au systeme nerveux central
US6919076B1 (en) 1998-01-20 2005-07-19 Pericor Science, Inc. Conjugates of agents and transglutaminase substrate linking molecules
US6958148B1 (en) 1998-01-20 2005-10-25 Pericor Science, Inc. Linkage of agents to body tissue using microparticles and transglutaminase
US7070799B1 (en) * 1998-02-10 2006-07-04 Generex Pharmaceuticals, Inc. Method for administering insulin to the buccal region
US6017545A (en) * 1998-02-10 2000-01-25 Modi; Pankaj Mixed micellar delivery system and method of preparation
US6221378B1 (en) 1998-02-10 2001-04-24 Generex Pharmaceuticals Incorporated Mixed micellar delivery system and method of preparation
US6350458B1 (en) 1998-02-10 2002-02-26 Generex Pharmaceuticals Incorporated Mixed micellar drug deliver system and method of preparation
AU753278B2 (en) * 1998-02-25 2002-10-10 Abbott Laboratories Butorphanol sustained release formulations
US6150420A (en) * 1998-06-01 2000-11-21 Theramax, Inc. Method for enhanced brain delivery of bupropion
US6608073B1 (en) 1998-10-14 2003-08-19 New Millennium Pharmaceutical Research, Inc. Intranasal codeine for the rapid suppression of cough and rapid relief of pain
US6806294B2 (en) 1998-10-15 2004-10-19 Euro-Celtique S.A. Opioid analgesic
FR2787029A1 (fr) * 1998-12-09 2000-06-16 Biovector Therapeutics Utilisation dans une composition pharmaceutique pour l'administration par voie nasale de vitamine b12 pour la delivrance d'agents actifs au systeme nerveux central
US7087215B2 (en) * 1998-12-21 2006-08-08 Generex Pharmaceuticals Incorporated Methods of administering and enhancing absorption of pharmaceutical agents
US6849263B2 (en) * 1998-12-21 2005-02-01 Generex Pharmaceutical Incorporated Pharmaceutical compositions for buccal delivery of pain relief medications
US6375975B1 (en) 1998-12-21 2002-04-23 Generex Pharmaceuticals Incorporated Pharmaceutical compositions for buccal and pulmonary application
US6451286B1 (en) 1998-12-21 2002-09-17 Generex Pharmaceuticals Incorporated Pharmaceutical compositions for buccal and pulmonary administration comprising an alkali metal alkyl sulfate and at least three micelle-forming compounds
GB9908921D0 (en) * 1999-04-19 1999-06-16 Britannia Pharmaceuticals Ltd Spray dispenser for opiod antagonists
WO2000076477A1 (fr) * 1999-06-16 2000-12-21 Nastech Pharmaceutical Co., Inc. Methodes et compositions permettant de traiter la douleur incidente
US6225343B1 (en) 1999-06-16 2001-05-01 Nastech Pharmaceutical Company, Inc. Compositions and methods comprising morphine gluconate
JP2003501467A (ja) * 1999-06-16 2003-01-14 ナステック・ファーマシューティカル・カンパニー・インコーポレーテッド 鼻内モルヒネを含む医薬用製剤および方法
GB9924797D0 (en) * 1999-10-20 1999-12-22 West Pharm Serv Drug Res Ltd Compound
US6863896B1 (en) 1999-10-26 2005-03-08 Chiron Corporation Plant lectins as mucosal adjuvants
US10179130B2 (en) 1999-10-29 2019-01-15 Purdue Pharma L.P. Controlled release hydrocodone formulations
ATE526950T1 (de) 1999-10-29 2011-10-15 Euro Celtique Sa Hydrocodon-formulierungen mit gesteuerter freisetzung
AU776666B2 (en) * 2000-02-08 2004-09-16 Euro-Celtique S.A. Tamper-resistant oral opioid agonist formulations
US6716449B2 (en) * 2000-02-08 2004-04-06 Euro-Celtique S.A. Controlled-release compositions containing opioid agonist and antagonist
PL357158A1 (en) * 2000-02-08 2004-07-12 Euro-Celtique, S.A. Controlled-release compositions containing opioid agonist and antagonist
US20040115133A1 (en) * 2000-05-10 2004-06-17 Wermeling Daniel P. Intranasal opioid compositions
US20060083691A1 (en) * 2000-05-10 2006-04-20 Wermeling Daniel P Intranasal opioid compositions, delivery devices and methods of using same
US6610271B2 (en) * 2000-05-10 2003-08-26 University Of Kentucky Research Foundation System and method for intranasal administration of lorazepam
US20020013331A1 (en) * 2000-06-26 2002-01-31 Williams Robert O. Methods and compositions for treating pain of the mucous membrane
US8257744B2 (en) * 2000-07-07 2012-09-04 Laboratorios Farmacéuticos Rovi, S.A. Pharmaceutical forms for the release of active compounds
FR2811227A1 (fr) * 2000-07-07 2002-01-11 Philippe Maincent Vecteurs particulaires destines a ameliorer l'absorption orale de principes actifs
EP1315533A4 (fr) * 2000-08-15 2007-06-27 Univ Kentucky Res Found Dispositif d'administration d'un medicament intranasal, programmable et a doses multiples
EP2283829A1 (fr) 2000-10-30 2011-02-16 Euro-Celtique S.A. Formulations d'hydrocodone à liberation lente
US20040176359A1 (en) * 2001-02-20 2004-09-09 University Of Kentucky Research Foundation Intranasal Benzodiazepine compositions
US20030044356A1 (en) * 2001-04-20 2003-03-06 Jin Auh Composition for nasal solution sprays having effective component of 1,2,3,9-tetrahydro-9-methyl-3-[(2-methyl-1H-imidazol-1-yl)methyl]-4H-carbazol-4-one)
US20110104214A1 (en) 2004-04-15 2011-05-05 Purdue Pharma L.P. Once-a-day oxycodone formulations
UA81224C2 (uk) * 2001-05-02 2007-12-25 Euro Celtic S A Дозована форма оксикодону та її застосування
US8329216B2 (en) * 2001-07-06 2012-12-11 Endo Pharmaceuticals Inc. Oxymorphone controlled release formulations
US9820982B2 (en) * 2001-07-06 2017-11-21 Endo Pharmaceuticals Inc. Oxymorphone controlled release formulations
CN1543338B (zh) 2001-08-16 2010-06-16 Cmp医疗有限公司 壳多糖微粒及其医疗用途
CA2459976A1 (fr) * 2001-09-26 2003-04-03 Penwest Pharmaceuticals Company Formulations d'opioides presentant un potentiel reduit pour des utilisations abusives
US20140271788A1 (en) 2013-03-15 2014-09-18 Monosol Rx, Llc Sublingual and buccal film compositions
WO2003066068A1 (fr) * 2002-02-01 2003-08-14 Intradigm Corporation Conjugues hpma-polyamine et utilisations associees
US7666876B2 (en) * 2002-03-19 2010-02-23 Vernalis (R&D) Limited Buprenorphine formulations for intranasal delivery
WO2004003145A2 (fr) * 2002-06-28 2004-01-08 Nastech Pharmaceutical Company Inc. Compositions et methodes permettant de moduler la physiologie de molecules d'adhesion jonctionnelle epitheliale en vue d'ameliorer l'administration de composes therapeutiques par voie muqueuse
JP2006021996A (ja) * 2002-07-04 2006-01-26 Dainippon Sumitomo Pharma Co Ltd 置換ヒドロキシピリジン化合物の抱合体
DK1551372T3 (en) * 2002-09-20 2018-07-23 Alpharma Pharmaceuticals Llc SEQUERATION SUBSTANCES AND RELATED COMPOSITIONS AND PROCEDURES
DE10248601B4 (de) * 2002-10-17 2006-05-24 Goldstein, Naum, Dr.habil.nat. Pharmazeutisches Mittel zur endonasalen Applikation bei der Behandlung von Krankheiten und Störungen des zentralen Nervensystems
US7445769B2 (en) * 2002-10-31 2008-11-04 Cadbury Adams Usa Llc Compositions for removing stains from dental surfaces and methods of making and using the same
GB0300531D0 (en) 2003-01-10 2003-02-12 West Pharm Serv Drug Res Ltd Pharmaceutical compositions
GB0302738D0 (en) * 2003-02-06 2003-03-12 Advanced Biopolymers As Composition
CA2523870A1 (fr) * 2003-04-30 2004-11-18 Nastech Pharmaceutical Company Inc. Procede de diagnostic et de traitement du cancer
AU2004235744A1 (en) * 2003-05-01 2004-11-18 Archimedes Development Limited Nasal administration of the LH-RH analog leuprolide
US20060263350A1 (en) * 2003-09-26 2006-11-23 Fairfield Clinical Trials Llc Combination antihistamine medication
US7968122B2 (en) * 2003-12-10 2011-06-28 Adventrx Pharmaceuticals, Inc. Anti-viral pharmaceutical compositions
US20050129679A1 (en) * 2003-12-15 2005-06-16 Nastech Pharmaceutical Company Inc. Method for opening tight junctions
GB0400804D0 (en) 2004-01-14 2004-02-18 Innoscience Technology Bv Pharmaceutical compositions
US20050175679A1 (en) * 2004-02-10 2005-08-11 Michael Moshman Controlled release formulations
GB0403938D0 (en) * 2004-02-21 2004-03-24 West Pharm Serv Drug Res Ltd Chitosan containing solution
US20050283004A1 (en) 2004-06-18 2005-12-22 Hopax Chemicals Manufacturing Co., Ltd. Alkylsulfonated polyaminosaccharides
GB0416328D0 (en) * 2004-07-21 2004-08-25 Univ Cardiff Use of dry powder compositions for pulmonary delivery
US7641892B2 (en) * 2004-07-29 2010-01-05 Cadburry Adams USA, LLC Tooth whitening compositions and delivery systems therefor
US7115561B2 (en) * 2004-09-22 2006-10-03 Patterson James A Medicament composition and method of administration
US20060183724A1 (en) * 2005-02-03 2006-08-17 Diliberti Charles E Compositions of unconjugated estrogens and methods for their use
WO2007025286A2 (fr) 2005-08-26 2007-03-01 The Board Of Trustees Of The Leland Stanford Junior University Methode d'administration de medicaments pour traitement de la douleur trigeminale
US20070212414A1 (en) * 2006-03-08 2007-09-13 Penwest Pharmaceuticals Co. Ethanol-resistant sustained release formulations
AU2007285472B2 (en) * 2006-03-30 2013-10-24 Engene, Inc. Non-viral compositions and methods for transfecting gut cells in vivo
KR101486228B1 (ko) 2006-06-19 2015-01-26 알파마 파머슈티컬스 엘엘씨 약제학적 조성물
US20080075768A1 (en) * 2006-07-21 2008-03-27 Vaughn Jason M Hydrophobic opioid abuse deterrent delivery system using opioid antagonists
CA2665726C (fr) * 2006-10-11 2016-04-19 Alpharma, Inc. Compositions pharmaceutiques
US20080275030A1 (en) * 2007-01-19 2008-11-06 Sveinbjorn Gizurarson Methods and Compositions for the Delivery of a Therapeutic Agent
WO2008091588A1 (fr) 2007-01-22 2008-07-31 Targacept, Inc. Administration intranasale, buccale ou sublinguale d'analogues de métanicotine
US20090124650A1 (en) * 2007-06-21 2009-05-14 Endo Pharmaceuticals, Inc. Method of Treating Pain Utilizing Controlled Release Oxymorphone Pharmaceutical Compositions and Instructions on Effects of Alcohol
US8802156B2 (en) 2007-11-14 2014-08-12 Laboratorios Farmacéuticos Rovi, S.A. Pharmaceutical forms for the release of active compounds
US8623418B2 (en) 2007-12-17 2014-01-07 Alpharma Pharmaceuticals Llc Pharmaceutical composition
US20090196890A1 (en) * 2007-12-17 2009-08-06 Alpharma Pharmaceuticals, Llc Pharmaceutical compositions
DK2706982T4 (da) 2011-05-13 2021-05-10 Euro Celtique Sa Intranasale farmaceutiske dosisformer omfattende naloxon
ES2712072T3 (es) 2011-07-20 2019-05-09 Torrent Pharmaceuticals Ltd Composición farmacéutica de tapentadol
CN106414415A (zh) 2014-03-14 2017-02-15 北卡罗来纳大学教堂山分校 用于抑制雄性生育力的小分子
US11389473B2 (en) 2015-01-07 2022-07-19 Tonix Pharmaceuticals Holding Corp. Magnesium-containing oxytocin formulations and methods of use
FR3032353B1 (fr) 2015-02-06 2017-03-10 Jacques Seguin Composition pharmaceutique et dispositif pour le traitement de la douleur
MX2018012351A (es) 2016-04-12 2019-02-07 Trigemina Inc Formulaciones de oxitocina que contienen magnesio y metodos de uso.
AU2017345767A1 (en) * 2016-10-21 2019-05-16 Somniferum Labs LLC Apparatus for controlled delivery of opioid and other medications
RS65027B1 (sr) 2017-01-11 2024-01-31 Torrent Pharmaceuticals Ltd Nazalna kompozicija tapentadola
US10292948B2 (en) 2017-01-11 2019-05-21 Torrent Pharmaceuticals Limited Tapentadol nasal composition
US11304968B2 (en) 2018-11-16 2022-04-19 Janssen Pharmaceutica Nv Pharmaceutical compositions comprising a hydroxyethylquercetin glucuronide
US10639294B2 (en) 2018-10-02 2020-05-05 Janssen Pharmaceutica Nv Pharmaceutical compositions comprising a hydroxyethylquercetin glucuronide metabolite
CN110257025B (zh) * 2019-07-03 2020-07-03 中国石油大学(华东) 水基钻井液用环糊精微球超高温降滤失剂及其制备方法以及水基钻井液和应用
CN113332419A (zh) * 2020-02-17 2021-09-03 江苏先声药业有限公司 一种含人尿激肽原酶的鼻喷剂及其制备方法
WO2022038403A1 (fr) * 2020-10-15 2022-02-24 Владимир ТИМКО Composition pharmaceutique à base de nalbuphine et/ou de ses sels pour administration nasale
KR102259589B1 (ko) * 2020-11-30 2021-06-02 (주)인벤티지랩 미소구체 제조 시스템 및 미소구체 제조 방법

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4464378A (en) * 1981-04-28 1984-08-07 University Of Kentucky Research Foundation Method of administering narcotic antagonists and analgesics and novel dosage forms containing same
GB8514665D0 (en) * 1985-06-11 1985-07-10 Eroceltique Sa Oral pharmaceutical composition
DE3602370A1 (de) * 1986-01-27 1987-08-06 Chrubasik Sigrun Verwendung von analgetica durch inhalation
GB8918879D0 (en) * 1989-08-18 1989-09-27 Danbiosyst Uk Pharmaceutical compositions
DE69122464T2 (de) * 1990-03-30 1997-02-20 Yasunori Morimoto Transdermal absorbierbares mittel mit morphin hydrochlorid
FR2665357B1 (fr) * 1990-07-31 1995-03-31 Aiache Jean Marc Procede de preparation d'une forme galenique bio-adhesive et forme galenique ainsi preparee.
JPH07505655A (ja) * 1992-04-13 1995-06-22 リージェンツ オブ ザ ユニバーシティ オブ ミネソタ アルコール乱用の処置のためのデルタオピオイドレセプター選択的ベンジリデン置換化モルヒナン

Also Published As

Publication number Publication date
JPH07503481A (ja) 1995-04-13
GB2277682A (en) 1994-11-09
AU3458093A (en) 1993-09-03
NO942787D0 (no) 1994-07-27
GB9413102D0 (en) 1994-08-31
CA2127805C (fr) 2004-03-30
DK0625044T3 (da) 1999-06-21
ES2123660T3 (es) 1999-01-16
ATE171872T1 (de) 1998-10-15
WO1993015737A1 (fr) 1993-08-19
EP0625044A1 (fr) 1994-11-23
CA2127805A1 (fr) 1993-08-19
AU665806B2 (en) 1996-01-18
DE69321458T2 (de) 1999-03-18
GB9202464D0 (en) 1992-03-18
EP0625044B1 (fr) 1998-10-07
NO942787L (no) 1994-07-27
DE69321458D1 (de) 1998-11-12
GB2277682B (en) 1995-12-20
US5629011A (en) 1997-05-13
JP3958352B2 (ja) 2007-08-15

Similar Documents

Publication Publication Date Title
NO942787D0 (no) Blanding for nasal administrering
IE860306L (en) Drug delivery system
EP0788346A4 (fr) Systemes d'administration de medicaments emulsionnes
NO306847B1 (no) Blanding for nasal administrering av nikotin
CA2181742A1 (fr) Reduction de l'irritation de la peau pendant l'administration de medicament par electrotransport
AU5954596A (en) Intravitreal microsphere drug delivery and method of prepara tion
EP0679390A3 (fr) Préparations pharmaceutiques vaporisables pour l'application topique
NO993195L (no) Blanding for administrasjon av medikamenter
AU4373993A (en) Treatment of vascular leakage syndrome and collagenase induced disease by administration of matrix metalloproteinase inhibitors
CA2004598A1 (fr) Aerosols medicinaux
EP1452172A3 (fr) Préparation pharmaceutique composite.
AU5159490A (en) Composition and method for administration of pharmaceutically active substances
FI944441A0 (fi) Määriteltyjä lipidejä sisältävä farmaseuttinen kantojärjestelmä
DE69311395D1 (de) Sphäroidische Arzneimittelformulierung
DK0630230T3 (da) Farmaceutiske inhaleringspræparater
CA2136985A1 (fr) Nouvel usage de l'hexaflumuron comme termiticide
CA2185119A1 (fr) Forme galenique pour l'administration d'un medicament dans une formulation liquide
AU1812395A (en) Film coated tablet of paracetamol and domperidone
EP0160501A3 (fr) Composé intranasal à effet prolongé et méthode d'utilisation
PT1003477E (pt) Sistema terapeutico transdermico (tts), contendo polimeros de (met)acrilato com grupos amonio para administracao de levonorgestrel
DK0904067T3 (da) Transdermalt indgivet dextromethorpan som hostestillende middel
PT100892A (pt) Sistema e processo para a administracao de um agente activo veterinario por via transdermica
GB2305606A (en) Drug delivery composition for the nasal administration of antiviral agents
CA2125281A1 (fr) Medicament contenant de l'ibuprofene a effet immediat et son utilisation
CA2129527A1 (fr) Composition pharmaceutique utilisable comme analgesique contenant l'acide (benzoyl-3 phenyl)-2 propionique-(r)

Legal Events

Date Code Title Description
MK1K Patent expired